Imatinib treatment of metastatic GIST: don't stop (believing)
- PMID: 20864404
- DOI: 10.1016/S1470-2045(10)70225-4
Imatinib treatment of metastatic GIST: don't stop (believing)
Comment on
-
Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial.Lancet Oncol. 2010 Oct;11(10):942-9. doi: 10.1016/S1470-2045(10)70222-9. Epub 2010 Sep 21. Lancet Oncol. 2010. PMID: 20864406 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources